Pre-existing adaptive immunity to the RNA-editing enzyme Cas13d in humans
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pre-existing adaptive immunity to the RNA-editing enzyme Cas13d in humans
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 28, Issue 7, Pages 1372-1376
Publisher
Springer Science and Business Media LLC
Online
2022-06-07
DOI
10.1038/s41591-022-01848-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro
- (2021) Chengle Zhuang et al. Frontiers in Molecular Biosciences
- Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
- (2021) Leo Swadling et al. NATURE
- Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
- (2020) Timothy R. Abbott et al. CELL
- Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice
- (2020) Haibo Zhou et al. CELL
- Massively parallel Cas13 screens reveal principles for guide RNA design
- (2020) Hans-Hermann Wessels et al. NATURE BIOTECHNOLOGY
- Modulation of metabolic functions through Cas13d-mediated gene knockdown in liver
- (2020) Bingbing He et al. Protein & Cell
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- CRISPR artificial splicing factors
- (2020) Menghan Du et al. Nature Communications
- Translating CRISPR-Cas Therapeutics: Approaches and Challenges
- (2020) Lavina Sierra Tay et al. CRISPR Journal
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
- (2019) Shayesteh R. Ferdosi et al. Nature Communications
- Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy
- (2019) Ana M. Moreno et al. Nature Biomedical Engineering
- Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
- (2018) Silvana Konermann et al. CELL
- Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
- (2018) Vijaya L. Simhadri et al. Molecular Therapy-Methods & Clinical Development
- High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
- (2018) Dimitrios L. Wagner et al. NATURE MEDICINE
- RNA editing with CRISPR-Cas13
- (2017) David B. T. Cox et al. SCIENCE
- Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages
- (2012) Emmanuel L Gautier et al. NATURE IMMUNOLOGY
- Licensing Virus-Specific T Cells to Secrete the Neutrophil Attracting Chemokine CXCL-8 during Hepatitis B Virus Infection
- (2011) Adam J. Gehring et al. PLoS One
- Dominant and diet-responsive groups of bacteria within the human colonic microbiota
- (2010) Alan W Walker et al. ISME Journal
- Jalview Version 2--a multiple sequence alignment editor and analysis workbench
- (2009) A. M. Waterhouse et al. BIOINFORMATICS
- Strategies to Modulate Immune Responses: A New Frontier for Gene Therapy
- (2009) Valder R Arruda et al. MOLECULAR THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started